- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
Canopy Growth Corp (CGC)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/24/2025: CGC (1-star) has a low Upturn Star Rating. Not recommended to BUY.
1 Year Target Price $3.67
1 Year Target Price $3.67
| 0 | Strong Buy |
| 2 | Buy |
| 4 | Hold |
| 1 | Sell |
| 3 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -66.99% | Avg. Invested days 16 | Today’s Advisory WEAK BUY |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 515.84M USD | Price to earnings Ratio - | 1Y Target Price 3.67 |
Price to earnings Ratio - | 1Y Target Price 3.67 | ||
Volume (30-day avg) 10 | Beta 2.14 | 52 Weeks Range 0.77 - 3.07 | Updated Date 12/23/2025 |
52 Weeks Range 0.77 - 3.07 | Updated Date 12/23/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -1.94 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -138.49% | Operating Margin (TTM) -22% |
Management Effectiveness
Return on Assets (TTM) -2.96% | Return on Equity (TTM) -62.07% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 428305929 | Price to Sales(TTM) 1.85 |
Enterprise Value 428305929 | Price to Sales(TTM) 1.85 | ||
Enterprise Value to Revenue 2.12 | Enterprise Value to EBITDA -1.06 | Shares Outstanding 342195956 | Shares Floating 342024858 |
Shares Outstanding 342195956 | Shares Floating 342024858 | ||
Percent Insiders 0.06 | Percent Institutions 11.19 |
Upturn AI SWOT
Canopy Growth Corp

Company Overview
History and Background
Canopy Growth Corporation was founded in 2013 as Tweed Inc., a medical cannabis producer in Smiths Falls, Ontario, Canada. It was one of the first publicly traded cannabis companies in the world. Key milestones include its initial public offering (IPO) on the Toronto Stock Exchange in 2014 and the TSX Venture Exchange in 2016, its listing on the NYSE in 2018, and significant international expansion. The company was a pioneer in the Canadian recreational cannabis market following legalization in 2018. Canopy has undergone significant restructuring and strategic shifts over the years, including divestitures and a focus on key markets.
Core Business Areas
- Cannabis and Cannabinoid-Based Products: Development, manufacturing, and sale of a wide range of cannabis products for recreational and medical use, including flower, pre-rolls, edibles, vapes, and oils. This also includes cannabinoid-based beverages and wellness products. Operates in Canada, the US, and other international markets where legally permitted.
- Branded Consumer Products: Focus on developing and marketing a portfolio of cannabis brands targeting various consumer segments. This includes premium and value offerings across different product categories.
- API and Seed-to-Sale Technology: Provision of cannabis-derived Active Pharmaceutical Ingredients (APIs) for medical applications and technology solutions for the cannabis industry, including seed-to-sale tracking systems.
Leadership and Structure
Canopy Growth is led by a Board of Directors and an executive management team. The current CEO is David Klein. The company has a geographically organized structure with dedicated teams for Canadian, US, and international operations, as well as functional departments for R&D, marketing, sales, and operations.
Top Products and Market Share
Key Offerings
- Description: One of Canopy's flagship brands, offering a wide variety of dried flower, pre-rolls, and other cannabis products. Known for its consistent quality and broad appeal in the Canadian market.
- Market Share Data: Market share varies by product category and region. Historically, Tweed has been a leading brand in the Canadian recreational market. Competitors include other major Canadian cannabis brands such as Aurora Cannabis brands (e.g., High Tide, Canna Farms), Cronos Group brands (e.g., Peace Naturals), and Tilray brands (e.g., Broken Coast, Afza).
- Product Name: Tweed (Brand)
- Description: A premium cannabis brand focusing on high-quality flower and select other product formats. Targets discerning consumers seeking a premium experience.
- Market Share Data: Smaller market share compared to Tweed due to its premium positioning. Competitors include other premium cannabis brands in Canada.
- Product Name: Doja (Brand)
- Description: A sports drink brand acquired by Canopy, focusing on hydration and recovery. While not directly a cannabis product, it is part of Canopy's diversification strategy and leverages its distribution channels.
- Market Share Data: Competes in the broader functional beverage and sports drink market. Major competitors include Gatorade (PepsiCo), Powerade (Coca-Cola), and other emerging sports drink brands. Canopy's share in this segment is currently small.
- Product Name: BioSteel (Functional Beverages)
- Description: High-end cannabis vaporizers developed by Storz & Bickel, a subsidiary of Canopy Growth. Known for advanced technology and quality.
- Market Share Data: Competes in the premium vaporizer market. Key competitors include Pax Labs, Arizer, and other high-end vaporizer manufacturers.
- Product Name: Storz & Bickel Vaporizers
Market Dynamics
Industry Overview
The global cannabis industry is characterized by rapid growth, evolving regulatory landscapes, and increasing consumer acceptance. Key trends include the expansion of medical and recreational markets, innovation in product formats (edibles, vapes, beverages), and a growing focus on wellness and R&D. However, the industry also faces challenges such as inconsistent regulations across jurisdictions, illicit market competition, and capital market volatility.
Positioning
Canopy Growth has positioned itself as a leading global cannabis company with a diversified product portfolio, a strong brand presence in Canada, and strategic investments in the US market. Its competitive advantages include its early mover status, established distribution networks, and ongoing innovation in product development and technology. The company is also leveraging its established infrastructure and brand recognition to explore opportunities in the US market as federal legalization progresses.
Total Addressable Market (TAM)
The total addressable market for cannabis is substantial and growing. Estimates for the global legal cannabis market vary, but many projections place it in the tens of billions of USD annually by the end of the decade. Canopy Growth is positioned to capture a significant portion of this TAM, particularly in North America, through its brand portfolio, product innovation, and strategic partnerships. However, achieving this will depend on regulatory developments, competitive pressures, and the company's ability to execute its global strategy effectively.
Upturn SWOT Analysis
Strengths
- Established brand recognition and portfolio in Canada.
- Significant retail and distribution footprint in Canada.
- Strong R&D capabilities and product innovation pipeline.
- Strategic partnerships and investments in the US market (e.g., with Constellation Brands).
- Ownership of reputable brands like Storz & Bickel.
Weaknesses
- Historically, significant operational losses and cash burn.
- Dependence on the Canadian recreational market, which is highly competitive.
- Complex regulatory environment impacting market access and profitability.
- Past strategic missteps and restructuring leading to investor uncertainty.
- Challenges in achieving consistent profitability across all segments.
Opportunities
- Expansion of the US cannabis market following potential federal legalization.
- Development of new cannabis-derived therapeutic applications.
- Growth in the global CBD and wellness product markets.
- Leveraging BioSteel brand for broader market penetration.
- Potential for international market expansion where regulations permit.
Threats
- Intense competition from both licensed and illicit operators.
- Evolving and inconsistent regulatory frameworks globally.
- Economic downturns impacting consumer discretionary spending.
- Adverse changes in public perception or health concerns related to cannabis.
- Increased consolidation and competition from larger CPG companies entering the market.
Competitors and Market Share
Key Competitors
- Aurora Cannabis (ACB)
- Cronos Group (CRON)
- Tilray Brands (TLRY)
Competitive Landscape
Canopy Growth faces intense competition in the Canadian market from established players like Aurora Cannabis and Tilray, as well as numerous smaller licensed producers. Its advantages lie in its established brands and distribution, but it is challenged by pricing pressures and market saturation. In the US, it competes indirectly through its BioSteel brand in the beverage market and aims to capitalize on future legalization. Its main disadvantages compared to some competitors are its historically lower profitability and ongoing need for restructuring.
Major Acquisitions
Storz & Bickel
- Year: 2018
- Acquisition Price (USD millions): 215
- Strategic Rationale: To acquire a leading global manufacturer of high-quality cannabis vaporizers, enhancing Canopy's product portfolio in the vaporizer segment and leveraging Storz & Bickel's brand reputation and technology.
BioSteel Sports Nutrition Inc.
- Year: 2019
- Acquisition Price (USD millions): 228
- Strategic Rationale: To enter the functional beverage market and diversify revenue streams beyond cannabis, leveraging BioSteel's established brand and distribution channels in sports nutrition.
Growth Trajectory and Initiatives
Historical Growth: Canopy Growth experienced rapid growth in its early years, driven by the burgeoning Canadian cannabis market and international expansion. However, growth has been more tempered in recent years, with strategic shifts and a focus on optimizing its portfolio and operations.
Future Projections: Analyst projections for Canopy Growth's future growth are mixed. They often depend on the pace of US federal legalization, the company's ability to achieve profitability, and its success in expanding its market share in key segments. Projections typically focus on revenue growth driven by market expansion and new product introductions, alongside efforts to reduce costs and improve margins. Specific EPS projections would likely remain negative in the short to medium term.
Recent Initiatives: Recent initiatives have included: streamlining its operational footprint, focusing on high-margin product categories, divesting non-core assets, and strengthening its US strategy through partnerships and potential future acquisitions. The company is also emphasizing its BioSteel brand and its pharmaceutical API business.
Summary
Canopy Growth Corporation is a pioneering cannabis company with a strong presence in Canada, a diversified product portfolio, and strategic aspirations in the US. While it boasts significant brand recognition and distribution, it faces intense competition and has historically struggled with profitability. The company's future success hinges on its ability to navigate the evolving regulatory landscape, execute its US market strategy effectively, and achieve sustainable financial performance.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Canopy Growth Corporation Investor Relations
- SEC Filings (EDGAR)
- Financial News Outlets (e.g., Bloomberg, Reuters, Wall Street Journal)
- Market Research Reports (e.g., BDSA, New Frontier Data)
- Analyst Reports
Disclaimers:
This information is for informational purposes only and does not constitute financial advice. Financial data and market share figures are estimates and subject to change. Investors should conduct their own due diligence before making any investment decisions. Past performance is not indicative of future results.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Canopy Growth Corp
Exchange NASDAQ | Headquaters Smiths Falls, ON, Canada | ||
IPO Launch date 2014-04-04 | CEO & Director Mr. Luc Mongeau | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 960 | Website https://www.canopygrowth.com |
Full time employees 960 | Website https://www.canopygrowth.com | ||
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis, hemp, and cannabis-related products in Canada, Germany, and Australia. It operates through four segments: Canada Cannabis, International Markets Cannabis, and Storz & Bickel, and This Works. The company offers dried flower and pre-rolled joints; extracts and concentrates, such as softgel capsules; cannabis edibles, including gummies; cannabis vapes; and oils, beverages, concentrates. It sells its products under the Tweed, 7ACRES, Deep Space, HiWay, Maitri, Twd., Spectrum Therapeutics, Canopy Medical, Storz & Bickel, Wana, and Claybourne brands, as well as DOJA, LivRelief, Ace Valley, and Vert brands. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

